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Abstract 
Background: Anthocyanins are a class of brightly colored, glycosylated flavonoid pigments that imbue their flower 
and fruit host tissues with hues of predominantly red, orange, purple, and blue. Although all anthocyanins exhibit pH-
responsive photochemical changes, distinct structural decorations on the core anthocyanin skeleton also cause dra-
matic color shifts, in addition to improved stabilities and unique pharmacological properties. In this work, we report 
for the first time the extension of the reconstituted plant anthocyanin pathway from (+)-catechin to O-methylated 
anthocyanins in a microbial production system, an effort which requires simultaneous co-option of the endogenous 
metabolites UDP-glucose and S-adenosyl-l-methionine (SAM or AdoMet).
Results: Anthocyanin O-methyltransferase (AOMT) orthologs from various plant sources were co-expressed in 
Escherichia coli with Petunia hybrida anthocyanidin synthase (PhANS) and Arabidopsis thaliana anthocyanidin 3-O-glu-
cosyltransferase (At3GT). Vitis vinifera AOMT (VvAOMT1) and fragrant cyclamen ‘Kaori-no-mai’ AOMT (CkmOMT2) were 
found to be the most effective AOMTs for production of the 3′-O-methylated product peonidin 3-O-glucoside (P3G), 
attaining the highest titers at 2.4 and 2.7 mg/L, respectively. Following modulation of plasmid copy number and 
optimization of VvAOMT1 and CkmOMT2 expression conditions, production was further improved to 23 mg/L using 
VvAOMT1. Finally, CRISPRi was utilized to silence the transcriptional repressor MetJ in order to deregulate the methio-
nine biosynthetic pathway and improve SAM availability for O-methylation of cyanidin 3-O-glucoside (C3G), the 
biosynthetic precursor to P3G. MetJ repression led to a final titer of 51 mg/L (56 mg/L upon scale-up to shake flask), 
representing a twofold improvement over the non-targeting CRISPRi control strain and 21-fold improvement overall.
Conclusions: An E. coli strain was engineered for production of the specialty anthocyanin P3G using the abundant 
and comparatively inexpensive flavonol precursor, (+)-catechin. Furthermore, dCas9-mediated transcriptional repres-
sion of metJ alleviated a limiting SAM pool size, enhancing titers of the methylated anthocyanin product. While micro-
bial production of P3G and other O-methylated anthocyanin pigments will likely be valuable to the food industry as 
natural food and beverage colorants, we expect that the strain constructed here will also prove useful to the orna-
mental plant industry as a platform for evaluating putative anthocyanin O-methyltransferases in pursuit of bespoke 
flower pigment compositions.
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Background
Many plant natural products and polyphenols have been 
associated with a diverse array of health benefits, particu-
larly in studies performed in  vitro, but controversy sur-
rounds many of these compounds with respect to their 
efficacy in humans despite the higher success rate of 
natural products versus other chemicals in Phase I test-
ing [1]. Nonetheless, industrial interest in these products 
has stagnated because of difficulty sourcing large quan-
tities of complex natural products, primarily due to low 
abundance of these compounds in raw plant extracts. 
Complicated syntheses suffer from low yield due to the 
presence of multiple stereocenters, and, thus, offer lit-
tle hope as a viable alternative to extraction [2]. Despite 
these difficulties, the brightly colored plant pigments 
known as anthocyanins are intriguing candidates for 
continued investigation due to their antioxidant proper-
ties, reported health benefits, and high potential for use 
as natural food and beverage colorants [3] since they 
already pervade nearly all diets.
Anthocyanins are pigmented flavonoids that are clas-
sically considered to be naturally biosynthesized in 
plants through the subsequent conversion of flavanones 
to dihydroflavonols by flavanone 3β-hydroxylase (F3H), 
dihydroflavonols to leucoanthocyanidins by dihydro-
flavonol 4-reductase (DFR), and leucoanthocyanidins 
to anthocyanidins by the α-ketoglutarate- and Fe(II)-
dependent anthocyanidin synthase (ANS). We have pre-
viously shown, however, that Escherichia coli expressing 
ANS are able to convert the flavan-3-ols afzelechin and 
catechin into the anthocyanidins pelargonidin and cya-
nidin, respectively [4]. This affords the opportunity for 
one-step biotransformation of the cheap and abundant 
precursor (+)-catechin into the unstable compound cya-
nidin, which can be significantly stabilized by glycosyla-
tion with UDP-glucose: 3-O-glycosyltransferase (3GT) 
to form cyanidin 3-O-glucoside. Such a strategy enables 
extension and exploration of the heterologous microbial 
anthocyanin biosynthetic pathway in the genetically trac-
table host, E. coli.
Traditional microbial workhorse hosts like E. coli and 
Saccharomyces cerevisiae remain an attractive option 
for both exploration of natural enzymatic tailoring reac-
tions and production of specialty natural products 
requiring several biosynthetic steps, primarily due to 
their well-characterized metabolisms and the wealth of 
advanced genetic tools [1, 5, 6]. Additionally, flavonoids 
and anthocyanins are convenient molecules for prob-
ing the capacity for co-option of specific endogenous 
microbial cosubstrates and cofactors; these polyphenols 
are easy to quantify, and most are readily permeable to 
cell membranes through passive and active diffusion (an 
important feature for substrate feeding, mutasynthesis 
[7–10], and co-culture studies [11] requiring inter-strain 
transport of pathway intermediates). Synthetic biology 
platforms developed for combinatorial heterologous gene 
expression in these hosts further facilitate rapid examina-
tion of genes from disparate sources [12], enabling aug-
mented synthetic pathway flux due to either improved 
enzymatic properties (Km and kcat), reduced inhibition 
from pathway intermediates and end products, or dis-
tinct heterologous expression capacities exhibited by 
divergent gene orthologs.
Prior to this work, our lab has successfully reconsti-
tuted many short flavonoid [11, 13, 14] and anthocyanin 
[3, 4, 15, 16] pathway segments in E. coli, which served as 
important testbeds to study endogenous cosubstrate or 
cofactor limitations [17, 18] toward the ultimate objective 
of de novo microbial production of complex polyphenols 
(starting with glucose and requiring construction of long 
pathways of 10–20 heterologous biosynthetic genes). 
Until now, however, we have not significantly extended 
these preliminary studies toward exploration of antho-
cyanin decoration. Instead, we have focused primar-
ily on UDP-glucose improvement—by supplementation 
or overexpression of relevant genes in central carbon 
metabolism—for conversion of the anthocyanidins (agly-
cones) pelargonidin and cyanidin into the anthocyanins 
(glycosides) pelargonidin 3-O-glucoside and cyanidin 
3-O-glucoside [3, 4, 15]. Other common anthocyanin 
modifications of interest besides hydroxylation include 
O-methylation [19] and C-methylation [20], aliphatic 
acylation (acetylation and malonylation) or aromatic 
acylation (cinnamoylation, hydroxycinnamoylation, 
hydroxybenzoylation, etc.) [21], and various glycosyla-
tions with distinct hexose or pentose donors at differ-
ent carbon positions on the core anthocyanin (including 
diglycosides or linear disaccharide/trisaccharide exten-
sions at a single carbon on the core structure) [22–24]. 
These decorations are desirable because they increase 
product stability and thus facilitate characterization and 
quantification in complex matrices like cell cultures. 
Additionally, such modifications change photochemi-
cal properties, making these tailored products attractive 
as natural pigments for the food, beverage, and cosmet-
ics colorant industries. A platform strain enabling rapid 
screening of putative anthocyanin tailoring enzymes 
from various plant sources using (+)-catechin or other 
inexpensive and abundant substrates would also prove 
useful for plant scientists.
Microbial anthocyanin O-methylation is one straight-
forward target modification that has not been examined 
to date in the context of a heterologous biosynthetic path-
way. Instead, most anthocyanin O-methyltransferases 
(AOMTs) have been characterized in planta or in vitro, 
following purification of heterologously-expressed 
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enzyme from E. coli. Given the existence of S-adenosyl-
methionine (SAM or AdoMet, the cosubstrate used by 
AOMTs to methylate anthocyanins primarily at the 3′- 
and 5′-hydroxyls) in the natural metabolism of E. coli, 
coupled with the proven capability of E. coli to express 
active AOMTs, we posited that endogenous SAM pools 
might be sufficient to achieve in  vivo anthocyanin 
O-methylation. Further supporting this hypothesis, E. 
coli has been utilized as a host for heterologous produc-
tion of other natural compounds that require SAM as a 
cosubstrate such as vanillate [25], N-acyl-homoserine 
lactones [26], polyketides [27], and even for biotransfor-
mations of flavonoids to their O-methylated counterparts 
[28–30]. Until recently, however, there has been little 
effort aimed at improving SAM pools for co-option by 
exogenous, SAM-dependent methyltransferase reactions. 
Primary strategies have been more traditional, including 
supplementation of l-methionine [31] (the immediate 
and limiting SAM precursor) and overexpression of SAM 
synthase (metK) [27–29], but recent advances in the field 
of synthetic biology are expediting our ability to explore 
novel metabolic engineering strategies. In particular, the 
advent of dCas9-mediated transcriptional repression 
(also known as CRISPR interference, or CRISPRi) has 
enabled rapid assessment of metabolic engineering inter-
ventions at a rate that was previously inaccessible [32, 
33], predominantly due to the ease and specificity of tar-
geting the programmable synthetic transcription factor 
dCas9 with a guide RNA (gRNA) designed to be comple-
mentary to a ~20 bp target DNA site [34]. Therefore, we 
turned to CRISPRi as a tool to quickly probe metabolic 
perturbations in E. coli for improved SAM availability 
and, as a result, increased anthocyanin O-methylation.
In this work, we present three major findings. We suc-
cessfully extend the microbial heterologous anthocyanin 
pathway to methylated anthocyanins for the first time, 
producing peonidin 3-O-glucoside (P3G) from the fla-
van-3-ol substrate (+)-catechin (Fig. 1). We demonstrate 
a simple alternative strategy for improving SAM avail-
ability for anthocyanin methylation by deregulating the 
methionine and SAM biosynthetic pathway, an approach 
that should be applicable for production of any methyl-
ated natural product. Finally, and in agreement with our 
previous work, we demonstrate that CRISPRi-mediated 
gene silencing is an effective tool for rapid assessment of 
metabolic engineering interventions, and we show that 
repression of transcriptional regulators can be a valuable 
tool for coordinated global metabolic perturbations.
Results
Anthocyanin O‑methyltransferases from different 
organisms exhibit distinct in vivo production capacities
A common starting point for improving production 
of heterologous natural products in microbial hosts is 
screening of known and putative enzymes catalyzing the 
same reaction but isolated from different donor organ-
isms [12]. Although the outcomes of such screens do not 
necessarily shed light on the rationale for exceptional 
performance of a particular ortholog in the context of 
the reconstituted pathway, these screens often uncover a 
gene or combination of genes that perform significantly 
better than others in a specific expression context. Fur-
ther investigation is often required to determine if an 
ortholog has better inherent enzymatic properties, is less 
sensitive to feedback inhibition, or is simply expressed 
at a more optimal level for production (not necessarily 
higher, but perhaps more balanced with the other het-
erologous pathways). With this in mind, we selected five 
previously validated anthocyanin O-methyltransferases 
(AOMTs) from the literature to test for extension of our 
synthetic heterologous pathway. AnthOMT (referred 
to in this work as SlAOMT for convenience) was origi-
nally characterized due to its role in anthocyanin diver-
sification in tomato (Solanum lycopersicum) seedlings 
[35]. CkmOMT2 was isolated as the major paralog—out 
















































Fig. 1 Heterologous anthocyanin pathway for conversion of the flavan-3-ol substrate (+)-catechin to the O-methylated anthocyanin product 
peonidin 3-O-glucoside (P3G). Substrate (green) was supplied in media, while cofactors (orange) required for each enzymatic step were co-opted 
from endogenous E. coli metabolism
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‘Kaori-no-mai’—responsible for methylation of the 
anthocyanin delphinidin 3,5-diglucoside [36]. VvAOMT1 
from grape has been characterized as a flavonol and 
anthocyanin 3′, 5′ O-methyltransferase [37–39]. PhMF1 
and PhMF2 are closely related paralogs from Petunia 
hybrida [37].
After all AOMTs were cloned into a high-copy vec-
tor (~50 copies) and sequence verified, each individual 
ortholog was co-expressed in modular fashion with a 
PhANS and At3GT cassette harbored on a compatible 
but lower copy vector (~15 copies) (Fig.  2a, b). Using 
this dual plasmid system, no additional cloning was 
required to compare orthologs. As seen in Fig.  2c, all 
AOMTs that were screened here were capable of per-
forming O-methylation of C3G to P3G in E. coli, mark-
ing what we believe to be the first example of engineered, 
multi-step microbial anthocyanin methylation reported 
to date. A strain lacking AOMT did not generate P3G, 
indicating that E. coli BL21 lacks endogenous anthocya-
nin O-methylation capability. Of note, AOMT orthologs 
from grape (VvAOMT1) and cyclamen (CkmOMT2) 
showed significant improvement in production capacity 
over the other examined orthologs, although even these 
two genes yielded relatively low titers (Fig. 2c, top). The 
relative production capacity differences between the 
orthologs may be due in part to substrate preferences; 
for example, data suggest that grape AOMT methylates 
anthocyanin 3-glycoside derivatives more efficiently than 
petunia AOMT orthologs that exhibit higher activity for 
anthocyanin (3-acyl) rutinoside 5-glucoside substrates 
[37, 40]. Coupled with potential differences in AOMT 
ortholog expression efficiencies, these differences in sub-
strate affinity could impact the conversion rate from C3G 
to P3G and lead to the disparate overall titers (C3G plus 
P3G) observed between strains. Despite achieving simi-
lar P3G titers, VvAOMT1 demonstrated nearly threefold 
higher conversion from C3G to P3G than CkmOMT2 
(Fig. 2c, bottom) in this pathway configuration.
Gene dosage affects C3G and P3G titers
Given the low overall titers of both C3G and P3G obtained 
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Fig. 2 Modular ortholog screen identifies several AOMTs that are capable of producing peonidin 3-O-glucoside (P3G) in E. coli. a The upstream 
module, encoded on low-copy ePathBrick vector pACM4, produces cyanidin 3-O-glucoside (C3G) from (+)-catechin and endogenous UDP-glucose, 
b all AOMT orthologs were cloned into compatible high-copy ePathBrick vector pETM6 to facilitate rapid screening of downstream modules follow-
ing combinatorial co-transformation with upstream module. The downstream module converts C3G and endogenous S-adenosylmethionine (SAM) 
to P3G, c ortholog screen reveals VvAOMT1 and CkmOMT2 as best P3G (blue) producers overall (top), while VvAOMT1 achieved best conversion of 
the final C3G to P3G step as demonstrated by the high final P3G:C3G titer ratio (bottom)
Page 5 of 14Cress et al. Microb Cell Fact  (2017) 16:10 
utilization and, thus, overall production would be improved 
by increasing expression of the upstream genes. We next 
evaluated the effect of gene dosage (mediated by plasmid 
copy number modulation) on P3G production. Expres-
sion of the upstream module composed of PhANS and 
At3GT was increased by transferring from the low-copy 
vector into high-copy vectors harboring one of the two 
best AOMTs (VvAOMT1 and CkmOMT2). In addition, an 
alternative upstream module composed of maltose binding 
protein (MBP)-tagged PhANS and At3GT was tested with 
each of the two best AOMTs in parallel. Although no strict 
hypothesis was posed as rationale for improved production 
using MBP tags, we had previously achieved high concen-
trations of soluble MBP-PhANS and MBP-At3GT dur-
ing in  vitro characterization (unpublished data), perhaps 
because cytosolic MBP (N-terminal membrane domain 
removed) is known to enhance solubility of its fusion part-
ners [41]. Moreover, modulation of protein translation 
rate through alteration of ribosome binding site (RBS) and 
N-terminal sequence (by fusion tag or alternative codon 
usage) is one of many methods used to balance expression 
of genes within a pathway [42, 43]. We thus speculated that 
even slight variation of upstream pathway expression due 
to the presence of N-terminal MBP tags could cause sig-
nificant changes in production either through improved 
solubility of the upstream enzymes or through the resulting 
altered balance with the downstream AOMT.
In total, four high-copy pathway variants were exam-
ined as shown in Fig. 3a. Shifting the upstream module 
from a low to high-copy plasmid dramatically improved 
accumulation of both C3G and P3G. However, conver-
sion from C3G to P3G was dampened relative to the ini-
tial screen, potentially highlighting an imbalance between 
the upstream and downstream modules. Compared to 
production levels achieved with the upstream module 
at low copy number, a higher gene dosage of PhANS and 
At3GT improved production by ~fivefold and is clearly 
important for driving flux into the heterologous pathway. 
Interestingly, however, utilization of MBP tags on the 
upstream enzymes improved production only when cou-
pled with VvAOMT1, while not affecting final titer when 
coupled with CkmOMT2. It is not clear if the MBP tag 
improved production in combination with VvAOMT1 
due to altered solubility and thus modulated intra-path-
way enzyme balance, due to altered translation rate, or 
due to some other unknown factor. In the end, the best 
high-copy configuration, which is composed of the MBP-
tagged upstream module and VvAOMT1, exhibited 
~ninefold higher production than the best configura-
tion from the ortholog screen. Despite the significantly 
improved production of P3G, high levels of remaining 
intermediate C3G suggested a potential limitation in 
cofactor availability for O-methylation of C3G. It should 
be noted here that increased gene dosage does not always 
correlate with increased protein production or increased 
metabolic flux; as such, we consider gene dosage modula-
tion (through copy number alteration or transcriptional/
translational control) as another strategy to alter expres-
sion context, which can sometimes lead to improved pro-








































Ortholog: VvAOMT1 VvAOMT1 CkmOMT2 CkmOMT2
MPB-tag: - + - +
Ortholog: VvAOMT1 VvAOMT1 CkmOMT2 CkmOMT2
MPB-tag: - + - +
Fig. 3 Gene dosage affects production of P3G. a Specifically, the upstream module was transferred from a low-copy vector into a single cassette 
with VvAOMT1 or CkmOMT2 on a high-copy vector, b increased copies of the upstream module led to ~fivefold improvement in P3G titer over the 
original constructs (Fig. 2). An additional, modest twofold improvement in overall P3G production (left), accompanied by a slight decrease in C3G to 
P3G conversion (right), was further achieved with VvAOMT1 (left) by utilizing an upstream module composed of MBP-fusions
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CRISPRi‑mediated deregulation of methionine 
and S‑adenosyl methionine biosynthesis improves P3G 
titers
While we have previously shown that endogenous pools 
of UDP-glucose are limiting for production of the antho-
cyanins C3G and pelargonidin 3-O-glucoside (similar to 
C3G, but monohydroxylated at the para-position of the 
B ring) from their corresponding aglycones in E. coli [4], 
we sought in this work to explore the potential limitation 
of SAM availability for O-methylation of anthocyanins. 
Several approaches have been previously utilized to over-
produce SAM in E. coli, but one surprisingly neglected 
strategy posed at the initiation of this work was deregula-
tion of SAM and methionine biosynthesis by simply silenc-
ing metJ, the ligand-responsive transcriptional repressor 
that naturally regulates production of methionine and 
SAM in response to feedback from SAM accumulation 
(and, to a lesser degree, accumulation of other structurally 
similar ligands) [45]. Although pathway deregulation is not 
always sufficient to engender accumulation of biosynthetic 
intermediates, it is often successful because of the coordi-
nated response—in some cases simultaneous repression, 
de-repression, and activation of genes at key regulatory 
nodes—that has naturally evolved to drive flux through a 
pathway in the absence of a feedback regulator’s cognate 
ligand (or in the presence of the cognate ligand, depending 
on whether a transcription factor binds or releases DNA in 
response to association with the ligand).
In prior work, we demonstrated the power of pathway 
deregulation to improve production of a target metabo-
lite with a single, focused genetic intervention intended 
to globally coordinate metabolism toward a defined 
objective. Specifically, we previously utilized CRISPRi/
dCas9-mediated transcriptional repression of fadR, the 
dual regulator of fatty acid biosynthesis and degradation, 
to enhance naringenin production through increased 
intracellular malonyl-CoA pool [32]. In the current 
effort, we implemented a similar approach to deregulate 
the methionine and SAM biosynthetic pathways using a 
single, pointed intervention intended to coerce E. coli to 
drive metabolic flux toward SAM through the otherwise 
highly regulated methionine pathway including the criti-
cal methionine synthase (MetH/MetE) node. In the pres-
ence of high SAM concentrations, the ligand-responsive 
transcriptional regulator MetJ is known to repress at 
least 12 genes from 9 promoters related to methionine 
and SAM biosynthesis in E. coli (Fig. 4) [46]. We hypoth-
esized that de-repression of the complete methionine and 
SAM biosynthetic pathways, mediated by the silencing of 
metJ, would result in increased SAM pools and thereby 
increased O-methylation of C3G.
Toward this goal, two CRISPR target sites (spac-
ers) were selected 5′ to the edge of existing NGG 
trinucleotides known as protospacer-adjacent motifs 
(PAMs) [47] and overlapping the −10 element of pro-
moter PmetJ3, the third and furthest downstream of three 
MetJ promoters (PmetJ1, PmetJ2, and PmetJ3). Targeting this 
location should cause dCas9-mediated occlusion of RNA 
polymerase from the third promoter (closest to the metJ 
start codon) and roadblocking of potential transcripts 
initiated from both upstream promoters (Fig.  5a). The 
outcome of metJ silencing is illustrated in Fig. 5b, which 
succinctly depicts the ensuing dysregulated signaling cas-
cade. In the absence of MetJ, at least 12 genes required 
for production of SAM, through methionine biosynthesis 
and uptake, are de-repressed. Of note, the ligand-respon-
sive transcriptional dual regulator MetR naturally acti-
vates transcription of methionine synthase (MetH/MetE) 
in presence of high concentrations of its cognate ligand 
l-homocysteine (immediate methionine precursor). 
Thus, the increased expression of MetR following its de-
repression likely complements elevated levels of homo-
cysteine, resulting in activation of methionine synthase; 
this can occur even at increased SAM concentrations due 
to the absence of MetJ, which would otherwise repress 
methionine synthase and upstream genes in response to 
elevated SAM.
To test the hypothesis that CRISPRi-mediated repres-
sion of metJ would improve SAM availability for O-meth-
ylation, compatible vectors bearing constitutive CRISPRi 
elements (dCas9, tracrRNA, and a minimal single-spacer 
CRISPR array) were co-transformed with the best vec-
tor from the gene dosage experiment (VvAOMT1 with 
MBP-tagged upstream module on high-copy vector). 
Interestingly, C3G titer was affected by addition of the 
non-targeting CRISPRi control vector to this strain. 
Although it is not clear why this occurred, we speculate 
that previously reported growth inhibition associated 
with expression of dCas9 and crRNA/gRNA [48] slightly 
altered the production capacity or induction optimum 
for this strain. Regardless, compared to the non-targeting 
spacer (previously used as a negative control in E. coli 
by other groups [49] and ours [32, 50]), both anti-metJ 
spacers improved production of P3G by approximately 
twofold (Fig.  5c), representing approximately 20-fold 
improvement over the best strain from the initial screen. 
Critically, the conversion of C3G to P3G by AOMT was 
also markedly improved by MetJ repression (Fig.  5d), 
which would likely be expected if AOMT’s cosubstrate 
SAM were limiting. Additionally, it is recommended that 
multiple gRNAs (or spacers) be selected against each 
CRISPRi target due to our current inability accurately 
predict gRNA (spacer) efficiency and specificity [51]. In 
this work, testing more than one metJ dCas9-binding site 
demonstrated two important points. Targeting one site 
achieved slightly higher production than targeting the 
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other site in a similar location, supporting the notion that 
non-intuitive changes in dCas9-binding site selection can 
affect production level. Secondly, similar improvements 
in C3G to P3G conversion for both metJ repression tar-
gets relative to the non-targeting control imply that 
improved production was indeed due to metJ repression; 
in other words, use of alternative dCas9-binding sites 
against a single target gene or promoter can serve as a 
specificity control for the assayed phenotype. Finally, the 
best metJ repression strain from this experiment (MetJ1) 
was used to demonstrate cultivation scale-up from 1 mL 
scale in multi-well plates to 25  mL working volume in 
125  mL non-baffled shake flasks. Production improved 
slightly upon scale-up to a final titer of 56.3 ± 0.6 mg/L 
(mean  ±  SEM of three independent experiments), a 
21-fold improvement over the best strain from the 
ortholog screen.
Discussion
This report details microbial O-methylated anthocyanin 
production as a case study for anthocyanin decoration in 
a platform strain, and the results indicate that the endog-
enous E. coli SAM pool is sufficient for designer meth-
ylation reactions but can be improved by targeted genetic 
interventions. For example, although SAM availability in 
E. coli has been the focus of a few other recent engineer-
ing efforts for O-methylation of natural products, the 
methionine and SAM biosynthesis deregulation strategy 
described herein could also facilitate in  vivo characteri-
zation of SAM-dependent methyltransferases catalyzing 
C-, N-, and S-dependent methylation of other natural 
products [52]. While our lab has strived in the past to 
systematically extend and connect flavonoid and antho-
cyanin pathways by improving cofactor and cosubstrate 
availability, this work was instead intended to demon-
strate that underexplored anthocyanin tailoring reactions 
can be rapidly tested in a model microbial system using 
the inexpensive and abundant substrate (+)-catechin. 
We anticipate that additional enzymatic reactions will 
be tested by others using a similar strategy, but con-
sideration should be devoted to availability of cognate 
cosubstrates; if a dearth of putative orthologs exists for a 
reaction of interest, it is conceivable that low intracellu-
lar cosubstrate concentration will impede conversion and 
product characterization. In any case, CRISPRi is a quick 
and easy alternative to gene deletion to improve metabo-
lite pools. A significant limitation to this platform strain 
is that products are constrained to C3G (3′-, 4′-hydroxy-
lated) as a precursor when feeding (+)-catechin as a 
substrate. There are a vast number of tailoring reactions 
that should be compatible with this C3G, but methylated 
anthocyanidins like petunidin and malvidin and their gly-
cosides are inaccessible unless an appropriate upstream 
substrate can be synthesized (difficult to control stereo-
chemistry) [53] or biosynthesized (not achieved to date, 






















































Fig. 4 Superpathway of methionine and SAM biosynthesis, with known transcriptional regulatory constraints indicated. Many genes involved 
in methionine biosynthesis and active, ATP-dependent uptake are part of the MetJ regulon and are thus subject to strong negative regulation 
(repression) by the eponymous ligand-responsive transcription factor MetJ (red) in presence of its cognate ligand SAM. Furthermore, the endog-
enous transcriptional activator of methionine synthase known as MetR (green) is repressed by MetJ:SAM, further attenuating methionine and SAM 
accumulation through de-activation of a critical node in the methionine biosynthetic pathway
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In addition to screening and characterizing antho-
cyanin tailoring reactions, the platform described here 
could ultimately prove feasible for industrial production 
of modified anthocyanins. Despite modest titers out-
lined here for the novel anthocyanin product P3G, very 
impressive and extensive work published during the 
preparation of this manuscript examined several solu-
tions to SAM limitation in E. coli K-12 MG1655(DE3) 
lineages for production of vanillate, an O-methylated 
natural product that had been produced in E. coli pre-
viously but suffered from low titers [25]. Combined 
deregulation of SAM biosynthesis through metJ deletion, 
feedback desensitization of enzymes catalyzing commit-
ted or important biosynthetic steps, and deregulation of 
SAM regeneration improved de novo vanillate titers by 




















































































































































Fig. 5 CRISPRi-mediated improvement of P3G production through increased SAM availability. a MetJ promoter (PmetJ) region architecture with 
anti-metJ CRISPR elements indicated (spacers in red, PAMs in yellow). Three promoters drive metJ expression (+1 sites in green and −35 and −10 
sites for PmetJ2 and PmetJ3 in blue), so CRISPR spacers were designed to target the downstream promoter PmetJ3 in order to simultaneously repress 
transcription from all three promoters, collectively indicated as PmetJ, b schematic representation of the regulatory cascade engendered by CRISPRi-
mediated deregulation of the metJ regulon. Repression of MetJ de-represses the metJ regulon, which is composed of at least twelve genes and nine 
promoters involved in methionine and SAM biosynthesis, including MetR (red). De-repression of MetR prompts activation of methionine synthase 
(metH/metE in green), the final step in methionine biosynthesis immediately preceding SAM synthase. The overall effect of MetJ silencing is unregu-
lated, increased flux through the methionine and SAM biosynthetic pathways, c both anti-metJ CRISPR spacers achieved twofold increase in P3G 
titer and approximately 2.5-fold increase in C3G to P3G conversion (d) relative to the non-targeting, scrambled CRISPR negative control spacer (NT), 
e sampling time course demonstrates that C3G (red circles) and P3G (blue circles) degradation occurs in culture and that optimization is required to 
reduce the detrimental effect of degradation on final titers, c, d utilize maximum titers obtained from optimal sampling conditions (blue arrows). 
Induction of slightly slower growing MetJ-repression strains (middle and right) was delayed by 1 h (black arrows) to ensure OD600 (gray squares) at 
induction was identical to NT strain (left), specifically corresponding to pre-determined optimal mid-log phase induction at OD600 ~5.1–5.4
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imply that SAM-dependent natural product biosynthe-
ses in E. coli at industrially relevant titers will likely be 
achievable. Interestingly, and in contrast to our work with 
anthocyanins, deletion of metJ alone was not sufficient to 
improve vanillate titers. It is possible that this difference 
stems from disparities in metabolite pools or regulation 
between B (used in this work) and K (used in [25]) E. coli 
lineages; alternatively, this could be attributed simply to 
distinct enzyme properties between the selected AOMT 
and catechol OMT used for vanillate production. Other 
strategies outlined in literature that have been reported 
to augment SAM production include supplementation of 
media with methionine and improvement of precursor 
ATP pools by reducing ATP usage in other reactions [54]. 
Another tactic that has not been tested but would likely 
prove synergistic with MetJ deletion in conjunction with 
these other strategies is overexpression of MetR, as it has 
been shown that the combination of SAM:MetJ shortage 
with overproduction of MetR induces overexpression of 
methionine synthase [55]. Nonetheless, a combination of 
all the aforementioned interventions with the UDP-glu-
cose improvements previously described by our lab could 
eventually lead to industrially relevant titers for these 
high-value, complex specialty anthocyanins.
Finally, although there are limitations to using CRIS-
PRi rather than gene deletions (potential for incomplete 
repression, commonly constructed on plasmid-based sys-
tems requiring antibiotics and prone to instability, etc.), 
there are significant advantages that make CRISPRi the 
unsurpassed tool for targeted gene silencing that exists 
today. First, design of CRISPRi constructs is swift and 
straightforward. CRISPRi vectors can be cloned, trans-
formed into production strains, and assessed with pre-
dictable results 2–3 days after target selection. If designed 
appropriately, inducible CRISPRi also enables complete 
repression (silencing) or tunable, partial repression of 
essential genes at any point of the growth phase, such 
as when sufficient biomass has accumulated; a related, 
highly attractive feature is the capacity to partially repress 
and somewhat predictably tune both essential and non-
essential genes with CRISPRi. Multiplexing can even be 
achieved following rapid hierarchical assembly of gRNAs 
or CRISPR arrays, and spacers that have been designed 
against conserved sequences in multiple strains are port-
able—i.e. the vectors can be transformed into any host 
background, facilitating faster assessment of multiple 
downregulations in disparate strains than any other exist-
ing method. Finally, CRISPRi can be used to gently coax 
cells into a rewired state with little effort; specifically, metJ 
repression is a “soft” strategy that achieves widespread 
metabolic perturbation (de-repression of many genes in 
the same pathway, simultaneously) without the metabolic 
burden associated with high-copy overexpression of many 
heterologous genes at once [56]. We anticipate that simi-
lar CRISPRi-mediated, systems-level interventions will 
expedite understanding of how new cosubstrates can be 
co-opted for novel anthocyanin decorations.
Conclusions
In this study, we have engineered a strain to serve as a 
platform for modular, rapid examination of anthocya-
nin tailoring enzymes. The strain only requires supple-
mentation of the inexpensive and abundant precursor 
(+)-catechin to generate anthocyanins for downstream 
modification. We exemplify the utility of this strain by 
engineering microbial production of an O-methylated 
anthocyanin for the first time. Combining classical meta-
bolic engineering principles and cutting-edge synthetic 
biology approaches, we significantly improved produc-
tion of our target compound P3G and gained insight 
about co-opting limiting AOMT cosubstrate pools. First, 
we screened AOMTs from disparate sources to isolate 
candidates with improved in vivo production capacities, 
a tried-and-true approach that should be considered at 
the outset of any metabolic engineering project. Next, we 
transferred the upstream genes to a high copy plasmid. 
The result was significantly improved flux, suggesting 
that these genes benefit from increased copy but imply-
ing that the effect of gene dosage on product titer should 
be assayed to explore expression space. Finally, we found 
that coordinated, global perturbation of SAM biosynthe-
sis was obtainable through a single CRISPRi intervention, 
leading to increased conversion through the anthocyanin 
O-methylation tailoring reaction. The metJ dysregulation 
strategy described in this and another recent report [25] 
should be useful for improving methylation of any natu-
ral product, but the general steps taken here should also 
be applicable for studying unique anthocyanin tailoring 
reactions that require co-option of distinct cosubstrates. 
Future efforts to integrate anthocyanin pathway genes 
into the genome of E. coli should also be undertaken to 
generate stable production strains lacking plasmids.
Methods
Strains and plasmids
A list of all E. coli strains and plasmids constructed in 
this work is provided in Table  1. All ortholog plasmids, 
pETM6 production plasmids, and CRISPRi plasmids 
generated for this manuscript have been made avail-
able to the community through Addgene (plasmids 
#86901-86917). Plasmid construction and propagation 
was performed in E. coli DH5α™. All anthocyanin pro-
duction experiments were performed using E. coli BL21 
Star™ (DE3) as a host for anthocyanin pathway and 
CRISPRi plasmids. Upstream genes PhANS and At3GT 
were obtained by PCR amplification (ACCUZYME mix, 
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Bioline) using plasmid pMAL-c2X-PhANS (unpublished) 
as a template, followed by traditional restriction ligation 
cloning into the ePathBrick destination vector pETM6. 
Fusions of PhANS and At3GT with cytosolic MBP (trun-
cated in pMAL-c2X to remove the N-terminal MBP 
membrane domain) were obtained in a similar manner, 
but the forward primer was designed to bind near the 
MBP tag start codon on pMAL-c2X in order to amplify 
the full fusion coding sequence through the stop codon of 
PhANS or At3GT. The five anthocyanin O-methyltrans-
ferase orthologs were synthesized as gBlocks (Integrated 
DNA Technologies) maintaining wild-type sequences, 
with any problematic internal restriction sites removed 
by silent mutation. Generic flanking regions were added 
to each gBlock, and universal primers M13F universal 
and M13R universal were used to amplify each AOMT 
prior to cloning into destination vector pETM6. The 
sequences of all primers used in this study are listed in 
Table 2. All gBlock sequences are provided in Additional 
file 1: Table S1. 
For cloning of individual genes, PCR amplicons and 
entry backbones were digested with the following restric-
tion enzyme (FastDigest, Thermo Fisher Scientific) com-
binations: PhANS (XbaI/XhoI), At3GT (NdeI/XhoI), 
MBP-PhANS (XbaI/XhoI), MBP-At3GT (XbaI/XhoI), 
VvAOMT1 (NdeI/XhoI), CkmOMT2 (NdeI/XhoI), 
PhMF1 (NdeI/XhoI), PhMF2 (NdeI/XhoI), SlAOMT 
(NdeI/XhoI), pETM6 (NdeI/XhoI or XbaI/XhoI). 
Digested amplicons and backbones were gel purified 
(E.Z.N.A MicroElute Gel Extraction Kit, Omega Bio-tek) 
Table 1 Strains and plasmids used in this study
Strain or plasmid name Properties/genotype References
E. coli strains
 E. coli DH5α™ F-Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 hsdR17 (rK−, mK+) phoA supE44 λ− thi-1 
gyrA96 relA1
Novagen
 E. coli BL21 Star™ (DE3) F-ompT hsdSB (rB−mB−) gal dcm rne131 (DE3) Invitrogen
E. coli plasmids
 pMAL-c2X-PhANS ColE1(AmpR), Petunia hybrida anthocyanidin synthase (PhANS) with N-terminal cytosolic MBP 
tag
Unpublished
 pMAL-c2X-At3GT ColE1(AmpR), Arabidopsis thaliana 3-O-glucosyltransferase (At3GT) with N-terminal cytosolic 
MBP tag
Unpublished
 pETM6-PhANS ColE1(AmpR), ePathBrick feature, PhANS This study
 pETM6-At3GT ColE1(AmpR), ePathBrick feature, At3GT This study
 pETM6-MBP-PhANS ColE1(AmpR), ePathBrick feature, PhANS with N-terminal MBP tag This study
 pETM6-MBP-At3GT ColE1(AmpR), ePathBrick feature, At3GT with N-terminal MBP tag This study
 pETM6-At3GT-m-PhANS ColE1(AmpR), ePathBrick feature, PhANS and At3GT in monocistronic configuration This study
 pACM4-At3GT-m-PhANS pACYC184(CmR), ePathBrick feature, PhANS and At3GT in monocistronic configuration This study
 pETM6-MBP-At3GT-m-MBP-PhANS ColE1(AmpR), ePathBrick feature, PhANS and At3GT with N-terminal MBP tags in monocistronic 
configuration
This study
 pETM6-VvAOMT1 ColE1(AmpR), ePathBrick feature, Vitis vinifera anthocyanin O-methyltransferase (VvAOMT1) This study
 pETM6-CkmOMT2 ColE1(AmpR), ePathBrick feature, fragrant cyclamen ‘Kaori-no-mai’ anthocyanin O-methyltrans-
ferase 2 (CkmOMT2)
This study
 pETM6-PhMF1 ColE1(AmpR), ePathBrick feature, Petunia hybrida anthocyanin O-methyltransferase 1 (PhMF1) This study
 pETM6-PhMF2 ColE1(AmpR), ePathBrick feature, Petunia hybrida anthocyanin O-methyltransferase 2 (PhMF2) This study
 pETM6-SlAOMT ColE1(AmpR), ePathBrick feature, Solanum lycopersicum anthocyanin O-methyltransferase 
(SlAOMT)
This study
 pETM6-VvAOMT1-m-At3GT-m-PhANS ColE1(AmpR), ePathBrick feature, VvAOMT1, PhANS, and At3GT in monocistronic configuration This study
 pETM6-VvAOMT1-m-MBP-At3GT-m-
MBP-PhANS
ColE1(AmpR), ePathBrick feature, VvAOMT1 and N-terminal MBP-tagged PhANS and At3GT in 
monocistronic configuration
This study
 pETM6-CkmOMT2-m-At3GT-m-PhANS ColE1(AmpR), ePathBrick feature, CkmOMT2, PhANS, and At3GT in monocistronic configuration This study
 pETM6-CkmOMT2-m-MBP-At3GT-m-
MBP-PhANS
ColE1(AmpR), ePathBrick feature, CkmOMT2 and N-terminal MBP-tagged PhANS and At3GT in 
monocistronic configuration
This study
 pdCas9 pACYC184(CmR), tracrRNA, cas9(D10A, H840A), non-targeting CRISPR spacer with two BsaI sites [49]
 pdCas9-M-MetJ1 pACYC184(CmR), tracrRNA, cas9(D10A, H840A), CRISPR spacer targeting MetJ promoter at 
position 1
This study
 pdCas9-M-MetJ2 pACYC184(CmR), tracrRNA, cas9(D10A, H840A), CRISPR spacer targeting MetJ promoter at 
position 2
This study
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and ligated (Rapid DNA Ligation Kit, Thermo Fisher 
Scientific) as appropriate to construct the single-gene 
vectors listed in Table  1. Ligation products were trans-
formed into DH5α and confirmed by Sanger sequencing 
(GENEWIZ, Inc.).
Using the ePathBrick subcloning procedure [57], 
At3GT and PhANS were then assembled into mono-
cistronic configuration (each gene flanked by its own 
T7 promoter and terminator) by ligation of restric-
tion digestion fragments from plasmid pETM6-At3GT 
(NheI/SalI) and pETM6-PhANS (AvrII/SalI), yielding 
plasmid pETM6-At3GT-m-PhANS. MBP-At3GT and 
MBP-PhANS fusions were assembled into monocis-
tronic configuration by ligation of restriction digestion 
fragments from plasmid pETM6-MBP-At3GT (NheI/
SalI) and pETM6-PhANS (AvrII/SalI), yielding plasmid 
pETM6-MBP-At3GT-m-MBP-PhANS. For co-expression 
of pETM6-harbored AOMTs with PhANS and At3GT, 
the two upstream genes were excised as a single cas-
sette from pETM6-At3GT-m-PhANS (AvrII/SalI) and 
subcloned into low-copy vector pACM4 (AvrII/SalI) 
to generate plasmid pACM4-At3GT-m-PhANS. Initial 
screening of AOMT orthologs was performed by co-
electroporation of all five pETM6-based AOMTs with 
ePathBrick-compatible pACM4-At3GT-m-PhANS into 
BL21 Star™ (DE3).
Next, the two best AOMTs, VvAOMT1 and CkmOMT2, 
were combined with either PhANS-m-At3GT or MBP-
PhANS-m-MBP-At3GT on the high-copy pETM6 
backbone. Ligation of pETM6-VvAOMT1 (NheI/SalI) 
with pETM6-At3GT-m-PhANS (AvrII/SalI) or pETM6-
MBP-At3GT-m-MBP-PhANS (AvrII/SalI) yielded plas-
mids pETM6-VvAOMT1-m-At3GT-m-PhANS and 
pETM6-VvAOMT1-m-MBP-At3GT-m-MBP-PhANS, 
respectively. Similarly, ligation of pETM6-CkmOMT2 
(NheI/SalI) with pETM6-At3GT-m-PhANS (AvrII/SalI) 




Plasmids used for CRISPRi/dCas9-mediated tran-
scriptional repression were assembled as described pre-
viously [32, 50]. All CRISPRi plasmids harbored dCas9, 
tracrRNA, and a minimal CRISPR array containing a 
single spacer. Each CRISPR element is transcription-
ally controlled by native Streptococcus pyogenes con-
stitutive promoters as in our previous work [32, 50]. 
Plasmid pdCas9, encoding a non-targeting spacer, was 
utilized as a negative control for CRISPRi interventions 
and as a base plasmid for cloning metJ repression spac-
ers. For both metJ repression targets, two 35 bp comple-
mentary and slightly offset oligonucleotides (Integrated 
DNA Technologies) containing the spacer sequences for 
dCas9 targeting were phosphorylated with T4 polynucle-
otide kinase (PNK, New England Biolabs) and annealed 
(37 °C for 30 min, 98 °C for 5 min, ramp down to 25 °C 
over 15 min) to build inserts for each metJ-repressor vari-
ant. Complementary offset oligos possessed the follow-
ing sequences: 5′-AAACN30G-3′ and 5′-N30CAAAA-3′, 
where N30 represents the genomic protospacer (target) 
sequence. Although spacer sequences in this CRISPR 
system are  ~30  bp, it has previously been shown that 
~10  bp are typically trimmed from the 5′ end of the 
spacer during crRNA-tracrRNA processing by RNAse 
III, yielding functional spacers of ~20 bp [47]. It is pos-
sible, however, that certain crRNAs retain the full length 
spacer as shown possible in the Type I-E CRISPR system 
from E. coli [58], but the effect that this would have on 
Table 2 Primers and oligonucleotides used in this study
Underline indicates full protospacer sequence




M13F universal GTTTTCCCAGTCACGACGTTG N/A N/A




ANS_XhoI_R CGATCTCGAGCTATTTAGATTCTTCAGCAGCAAC N/A N/A
3GT_NdeI_F GCATCATATGACCAAACCCTCCGACC N/A N/A




MetJ1_KD_F AAACTCACGGTAACGCCTGTACGGTAAACTATGCG GCCTGTACGGTAAACTATGC GGG
MetJ1_KD_R AAAACGCATAGTTTACCGTACAGGCGTTACCGTGA
MetJ2_KD_F AAACCTGACCGTAAACCCGCATAGTTTACCGTACG ACCCGCATAGTTTACCGTAC AGG
MetJ2_KD_R AAAACGTACGGTAAACTATGCGGGTTTACGGTCAG
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dCas9-mediated transcriptional repression of distinct 
targets in E. coli is currently unknown.
Phosphorylated and annealed inserts were then cloned 
into the recipient vector, pdCas9, at two adjacent BsaI 
sites in the minimal, single-spacer CRISPR array using a 
one-pot Golden Gate reaction with BsaI (New England 
Biolabs) and T7 DNA ligase (New England Biolabs). Plas-
mid pdCas9 was a gift from Luciano Marraffini (Addgene 
plasmid #46569). See Table 2 for a list of oligonucleotides 
used for construction of CRISPRi plasmids and their cor-
responding protospacer sequences.
Culture conditions
To facilitate rapid screening of constructs and expression 
conditions, all experiments were performed in 1 mL cul-
tures in polypropylene deep 48-well plates (5 mL, VWR) 
covered with breathable rayon film (VWR). A semi-rich 
defined media known as AMM, supplemented with 2% 
glucose and appropriate antibiotics (80 μg/mL ampicillin 
and 25  μg/mL chloramphenicol, as necessary), was uti-
lized for all liquid culture growth, including overnights 
and production experiments. AMM has been described 
previously [32] and is composed of 3.5  g/L KH2PO4, 
5.0  g/L K2HPO4, 3.5  g/L (NH4)2HPO4, 2  g/L casamino 
acids, 100 mL 10× MOPS mix (83.72 g/L MOPS, 7.17 g/L 
tricine, 28  mg/L FeSO4·7H2O, 29.2  g/L NaCl, 5.1  g/L 
NH4Cl, 1.1 g/L MgCl2, 0.48 g/L K2SO4, and 0.2 mL micro-
nutrient stock), 1 mL 1 M MgSO4, 0.1 mL 1 M CaCl2, and 
1 mL 0.5 g/L thiamine HCl. Micronutrient stock contains 
0.18 g/L (NH4)6Mo7O24, 1.24 g/L H3BO3, 0.12 g/L CuSO4, 
0.8 g/L MnCl2, and 0.14 g/L ZnSO4.
For production experiments, glycerol stocks of BL21 
Star™ (DE3) expression strains containing anthocya-
nin pathway plasmids and, in some cases, CRISPRi 
plasmids were first streaked onto LB agar plates con-
taining appropriate antibiotics. Following overnight 
growth on solid media, cells were inoculated into a 
single well of a polypropylene deep 48-well plate con-
taining 1  mL liquid media. After 14  h growth in liquid 
culture at 225  rpm and 37  °C, all strains were subcul-
tured by 50× back-dilution into fresh, room tempera-
ture media (20  μL overnight culture into 1  mL AMM), 
and incubated at 225 rpm and 30  °C. Next, 10 μL 100× 
substrate (1  g/L (+)-catechin final concentration) stock 
dissolved in dimethylformamide:ethanol (8:2, v/v) and 10 
μL 100× inducer (1 mM IPTG final concentration) stock 
were added sequentially by multichannel pipette at the 
optimal cell density as measured on a Biotek Synergy 4 
Microplate Reader, and cultures were further incubated 
at 225 rpm and 30 °C to allow conversion of (+)-catechin 
to P3G. Cultures were sampled for anthocyanin quanti-
fication 18–22  h post-induction with the exception of 
sampling timecourse studies. All production experiments 
were performed in biological triplicate, and reported 
production values represent mean and SEM as quantified 
by HPLC.
Anthocyanin quantification by HPLC
Crude anthocyanin mixtures were extracted from 
200 μL culture by addition of an equal volume of acidi-
fied methanol (1% HCl, v/v), followed by brief vortexing 
and centrifugation at 21,000×g for 10 min to remove cell 
debris (Fig. 6). The aglycone cyanidin was not quantified 
due to rapid degradation in culture, typically resulting 
in its absence from HPLC traces at final sampling time 
points. C3G and P3G stock solutions of known concen-
trations were prepared by dissolving analytical standards 
(Alkemist Labs) in DMSO and were stored at −20  °C, 
and standard curves were prepared fresh (by dilution into 
methanol) at appropriate concentrations for quantify-
ing production from the engineered strains. Extracts and 
standards were injected (25  μL) for analysis on an Agi-
lent 1200 series HPLC equipped with a ZORBAX SB-C18 
StableBond analytical column (150 mm × 4.6 mm, 5 μm) 
and a diode array detector (DAD). Acetonitrile (solvent 
A) and water (solvent B), both containing 0.1% formic 
acid, were used as mobile phases. A flow rate of 1  mL/
min was used with the following gradient: 10–40% A 
(0–10 min) and 10–40% A (10–15 min). C3G (retention 
time = 4.8 min) and P3G (retention time = 5.5 min) were 
quantified against standard curves by peak area integra-
tion at 520 nm.
a bAcidified culture




Fig. 6 Crude cellular extract containing P3G and C3G exhibits bril-
liant color associated with anthocyanin production. a E. coli culture 
harvested after approximately 12 h induction. 2× dilution of the 
culture with acidified methanol (1% HCl, v/v) immediately develops 
the brilliant red color shown here, b following centrifugation to 
remove cellular debris, the crude extract exhibits pH-dependent 
color change. Specifically, C3G and P3G undergo bathochromic shift 
to longer wavelength (lower frequency) with addition of acid and 
hypsochromic shift to shorter wavelength (higher frequency) with 
addition of base, which manifests as the red and purple hues shown in 
the vials on the left and right, respectively
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